Antibody

1,010개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-4 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved1,010 programs
AntibodyLimited DatastaleShahid Beheshti University of M…Phase 3

injection of bevacizumab and erythropoietin (injection of bevacizumab and erythropoietin)

Refractory Diabetic Macular Edema · FRα

#FR#Antibody#Phase3#monoclonal-antibody#RefractoryDiabeticMacularEdema+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

THP (investigator-selected taxane/trastuzumab/pertuzumab, investigator-selected taxane/trastuzumab/pertuzumab (THP))

Neoadjuvant Therapies for HER2+ Breast Cancer · HER2

#HER2#Antibody#Phase3#monoclonal-antibody#NeoadjuvantTherapiesforHER2+Brea+1
Trials 1Status Active
AntibodyLimited DatastalePeking Union Medical CollegePhase 2

iparomlimab + tuvonralimab (iparomlimab + tuvonralimab)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#monoclonal-antibody#PrecisionTherapy+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPhase 2

pembrolizumab (Keytruda, ipilimumab +pembrolizumab +durvalumab)

Lung Cancer; Liver Cancer · Lung Cancer

#LungCancer#Antibody#Phase2#monoclonal-antibody#LiverCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleBeijing HospitalPhase 2

irinotecan, cetuximab, envafolimab (irinotecan, cetuximab, envafolimab)

RAS Mutation; Metastatic Colorectal Cancer · RAS Mutation

#RASMutation#Antibody#Phase2#monoclonal-antibody#MetastaticColorectalCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleUniversitätsklinikum Hamburg-Ep…Phase 3

Isa-KD (isatuximab/carfilzomib/dexamethasone, isatuximab/carfilzomib/dexamethasone (Isa-KD))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#monoclonal-antibody#Universittsklinikum
Trials 1Status Discontinued
AntibodyLimited DatastalePeking Union Medical CollegePhase 2

ivonescimab + investigator-choice platinum doublet+ (ivonescimab + investigator-choice platinum doublet+)

Salivary Gland Carcinoma; Precision Therapy · Salivary Gland Carcinoma

#SalivaryGlandCarcinoma#Antibody#Phase2#monoclonal-antibody#PrecisionTherapy+1
Trials 1Status Recruiting
AntibodyLimited DatastaleEli LillyPhase 2

ixabepilone + cetuximab (ixabepilone + cetuximab)

Triple Negative Locally Advanced Non-resectable Breast Cancer; Metastatic Breast Cancer · Triple Negative Locally Advanced Non-res

#TripleNegativeLocallyAdvancedNon#Antibody#Phase2#monoclonal-antibody#MetastaticBreastCancer+1
Trials 1Status Active
AntibodyLimited DatastaleCytoDyn, Inc.Preclinical

PRO 140 (leronlimab, leronlimab (PRO 140))

TNBC; TNBC - Triple-Negative Breast Cancer · TNBC

#TNBC#Antibody#Preclinical#monoclonal-antibody#TNBC-Triple-NegativeBreastCancer+1
Trials 1Status Active
AntibodyLimited DatastaleSeagen Inc.Phase 1

lintuzumab (lintuzumab)

Myelodysplastic Syndrome (MDS) · Myelodysplastic Syndrome (MDS)

#MyelodysplasticSyndromeMDS#Antibody#Phase1#monoclonal-antibody#Seagen
Trials 1Status Active
AntibodyLimited DatastaleKiniksa Pharmaceuticals Interna…Phase 3

mavrilimumab (mavrilimumab)

COVID · COVID

#COVID#Antibody#Phase3#monoclonal-antibody#Kiniksa
Trials 1Status Active
AntibodyLimited DatastaleChinese PLA General HospitalPhase 2

metoprolol, infliximab, etanercept, tocilizumab and/or other agents (metoprolol, infliximab, etanercept, tocilizumab and/or other agents)

Solid Tumor; Hematological Malignancy · Solid Tumor

#SolidTumor#Antibody#Phase2#monoclonal-antibody#HematologicalMalignancy+1
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

miFL + bevacizumab (miFL + bevacizumab)

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleBeth ChristianPhase 2

milatuzumab (milatuzumab)

Lymphoma · Lymphoma

#Lymphoma#Antibody#Phase2#monoclonal-antibody#Beth
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 2

RO5072759 (obinutuzumab, obinutuzumab (RO5072759))

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#monoclonal-antibody#Roche
Trials 1Status Active
AntibodyLimited DatastaleAmgenPhase 2

EGFR inhibitors (panitumumab, panitumumab (EGFR inhibitors))

Recurrence Free Survival · EGFR

#EGFR#Antibody#Phase2#monoclonal-antibody#RecurrenceFreeSurvival+1
Trials 1Status Recruiting
AntibodyLimited DatastaleVaccinex Inc.Phase 2

pembrolizumab (Keytruda, pepinemab + pembrolizumab)

Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC) · Recurrent/Metastatic Squamous Cell Carci

#RecurrentMetastaticSquamousCellC#Antibody#Phase2#monoclonal-antibody#Recurrent+2
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

P (pertuzumab, pertuzumab (P))

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 2

trastuzumab (Herceptin, pertuzumab + trastuzumab + docetaxel)

Non Small Cell Lung Cancer Metastatic; Non Small Cell Lung Cancer Stage III · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#NonSmallCellLungCancerMetastatic+2
Trials 1Status Active
AntibodyLimited DatastaleMemorial Sloan Kettering Cancer…Phase 2

pilimumab (pilimumab)

Advanced Stage Non-small Cell Lung Cancer · Advanced Stage Non-small Cell Lung Cance

#AdvancedStageNon-smallCellLungCa#Antibody#Phase2#monoclonal-antibody#Memorial
Trials 1Status Active

49 / 51 pages

← PreviousNext →